Skip to main content
Equibles

TUDOR INVESTMENT CORP ET AL

Position in ZVRA — Zevra Therapeutics, Inc.

CIK 923093 STAMFORD, CT
Back to ZVRA Full portfolio

Position in ZVRA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,951,931
+$1,822,156 QoQ
Shares Held
415,058
-6.3% QoQ
Ownership
0.699%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#24
of 158 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority Sole 50% Shared 50% None 0%

Common Shares in ZVRA Over Time

Shares Held

Position Value (USD)

Derivatives in ZVRA

reported options exposure · as of Jun 30, 2026
CallValue
$1,302,072
CallShares
90,800
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TUDOR INVESTMENT CORP ET AL holds $414,135,114 across 107 Biotechnology names. ZVRA ranks #14 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TECH
BIO-TECHNE Corp
 943,287 $66,643,226
2 RPRX
Royalty Pharma plc
 610,736 $34,243,967
3 XENE
Xenon Pharmaceuticals Inc.
 545,387 $32,919,559
4 ABVX
Abivax S.A.
 187,335 $24,964,262
5 INSM
INSMED Inc
 195,391 $20,832,588
6 MLYS
Mineralys Therapeutics, Inc.
 738,370 $19,921,222
7 ABCL
AbCellera Biologics Inc.
 2,063,191 $16,196,049
8 QURE
uniQure N.V.
 328,889 $15,148,627

All Filings in ZVRA

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,951,931 415,058
2026-06-30 $1,302,072 90,800
2026-03-31 $4,129,775 443,109
2026-03-31 $1,236,764 132,700
2025-12-31 $1,026,816 114,600
2025-12-31 $6,201,189 692,097
2025-09-30 $388,008 40,800
2025-09-30 $4,259,490 447,896